Cargando…

Pan-cancer analysis reveals that G6PD is a prognostic biomarker and therapeutic target for a variety of cancers

BACKGROUND: Despite accumulating evidence revealing that Glucose-6-phosphate dehydrogenase (G6PD) is highly expressed in many tumor tissues and plays a remarkable role in cancer tumorigenesis and progression, there is still a lack of G6PD pan-cancer analysis. This study was designed to analyze the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Tao, Li, Bin, Shu, Xin, Pang, Jiahui, Wang, Heping, Cai, Xianghao, Liao, Yingying, Xiao, Xiaolong, Chong, Yutian, Gong, Jiao, Li, Xinhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435888/ https://www.ncbi.nlm.nih.gov/pubmed/37601657 http://dx.doi.org/10.3389/fonc.2023.1183474

Ejemplares similares

Pan-Cancer analysis shows that ACO2 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including hepatocellular carcinoma
por: Wang, Zhen, et al.
Publicado: (2022)

Characteristics of Pan-Cancer Patients With Ultrahigh Tumor Mutation Burden
por: Yuan, Hong, et al.
Publicado: (2021)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

Turbulence of glutamine metabolism in pan-cancer prognosis and immune microenvironment
por: He, Songjiang, et al.
Publicado: (2022)

Pan-cancer analysis of kinesin family members with potential implications in prognosis and immunological role in human cancer
por: Zhong, Ming, et al.
Publicado: (2023)

The role of toll-like receptors (TLRs) in pan-cancer
por: Huang, Runzhi, et al.
Publicado: (2022)

The Potential of panHER Inhibition in Cancer
por: Wang, Xiaochun, et al.
Publicado: (2015)

Machine Learning-Based Comparative Analysis of Pan-Cancer and Pan-Normal Tissues Identifies Pan-Cancer Tissue-Enriched circRNAs Related to Cancer Mutations as Potential Exosomal Biomarkers
por: Wang, Xuezhu, et al.
Publicado: (2021)

Functional and embedding feature analysis for pan-cancer classification
por: Lu, Jian, et al.
Publicado: (2022)

Identification of alternative splicing associated with clinical features: from pan-cancers to genitourinary tumors
por: Duan, Chen, et al.
Publicado: (2023)

LAMP2 as a Biomarker Related to Prognosis and Immune Infiltration in Esophageal Cancer and Other Cancers: A Comprehensive Pan-Cancer Analysis
por: Liu, Shan-peng, et al.
Publicado: (2022)

Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma
por: Yu, Mingxue, et al.
Publicado: (2021)

Prognostic Pathways Guide Drug Indications in Pan-Cancers
por: Meng, Fanlin, et al.
Publicado: (2022)

Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancer
por: Zhou, Cankun, et al.
Publicado: (2022)

Circular RNA HIPK3: A Key Circular RNA in a Variety of Human Cancers
por: Wen, Jingyuan, et al.
Publicado: (2020)

HILPDA Is a Prognostic Biomarker and Correlates With Macrophage Infiltration in Pan-Cancer
por: Liu, Chengdong, et al.
Publicado: (2021)

A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors
por: Ding, Qiang, et al.
Publicado: (2023)

Targeting Tim-3 in Cancer With Resistance to PD-1/PD-L1 Blockade
por: Tian, Tian, et al.
Publicado: (2021)

Pan-Cancer Prognostic Role and Targeting Potential of the Estrogen-Progesterone Axis
por: Shen, Yu-ting, et al.
Publicado: (2021)

A Pan-Cancer Analysis of the Oncogenic Role of Nuclear Transport Factor 2 in Human Cancers
por: Li, Yu, et al.
Publicado: (2022)

A pan-cancer analysis of the oncogenic role of zinc finger protein 419 in human cancer
por: Zhu, Weizhen, et al.
Publicado: (2022)

Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer Analysis
por: Xu, Wenhua, et al.
Publicado: (2021)

The Combination Options and Predictive Biomarkers of PD-1/PD-L1 Inhibitors in Esophageal Cancer
por: Yang, Hui, et al.
Publicado: (2020)

Immune Infiltration of MMP14 in Pan Cancer and Its Prognostic Effect on Tumors
por: Li, Minde, et al.
Publicado: (2021)

Prognostic and Immunological Role of FUN14 Domain Containing 1 in Pan-Cancer: Friend or Foe?
por: Yuan, Qingchen, et al.
Publicado: (2020)

Pan-Cancer Analysis of NOS3 Identifies Its Expression and Clinical Relevance in Gastric Cancer
por: Zou, Dan, et al.
Publicado: (2021)

Pan-Cancer Analysis Reveals Genomic and Clinical Characteristics of TRPV Channel-Related Genes
por: Wang, Xiaoxuan, et al.
Publicado: (2022)

Comprehensive Pan-Cancer Analysis of TRPM8 in Tumor Metabolism and Immune Escape
por: Zhang, Wei, et al.
Publicado: (2022)

Prognostic and Immunological Role of Gasdermin E in Pan-Cancer Analysis
por: Zhang, Zheng, et al.
Publicado: (2021)

Comprehensive prognostic and immunological analysis of CCT2 in pan-cancer
por: Lv, Wenming, et al.
Publicado: (2022)

Pan-cancer analysis of trophinin-associated protein with potential implications in clinical significance, prognosis, and tumor microenvironment in human cancers
por: Li, Zhenfen, et al.
Publicado: (2022)

Pan-cancer investigation of C-to-U editing reveals its important role in cancer development and new targets for cancer treatment
por: Guo, Mengbiao, et al.
Publicado: (2023)

A Comprehensive Prognostic and Immune Analysis of SLC41A3 in Pan-Cancer
por: Liu, Jun, et al.
Publicado: (2021)

Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8(+) T Cells by Inhibiting IL-17 Signaling Transduction in Breast Cancer
por: Shuai, Chong, et al.
Publicado: (2020)

Pan-cancer analysis and in vitro validation of the oncogenic and prognostic roles of AURKA in human cancers
por: Yang, Chuang, et al.
Publicado: (2023)

WASF2 Serves as a Potential Biomarker and Therapeutic Target in Ovarian Cancer: A Pan-Cancer Analysis
por: Yang, Xiaofeng, et al.
Publicado: (2022)

PET/CT Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients
por: Rong, Xiaoxiang, et al.
Publicado: (2022)

Meta-Analysis of Efficacy From CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients
por: Xu, Li, et al.
Publicado: (2022)

Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma
por: Zhang, Fang, et al.
Publicado: (2023)

Pan-Immune-Inflammation Value: A New Prognostic Index in Operative Breast Cancer
por: Lin, Fei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kr926q5uvev8vgke4pori1j52e